Figure 8.

Concentration of PI3K in breast cancer MCF-7 cells following 24 h incubation with anti-MUC1 (10 and 20 µg/ml), Pt12 (10 and 20 µM), Pt12 + anti-MUC1 (10 µM + 10 µg/ml and 20 µM + 10 µg/ml), cisplatin (10 and 20 µM), cisplatin + anti-MUC1 (10 µM + 10 µg/ml and 20 µM + 10 µg/ml). The results are representative of data from 3 independent experiments. Data presented as the mean ± standard deviation. MUC1, mucin 1; Pt12, platinum(II) complex; PI3K, phosphoinositide 3 kinase; ns, not significant.